Septic encephalopathy: Does inflammation drive the brain crazy?

Revista Brasileira de Psiquiatria

Volumn 36, Issue 3, 2014, Pages 251-258

  Dal Pizzol, Felipe ^a   Tomasi, Cristiane D ^a   Ritter, Cristiane ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Acetylcholine; Amines; GABA; Inflammation; Sepsis associated encephalopathy

Indexed keywords

4 AMINOBUTYRIC ACID; AMINE; CYTOKINE;

BRAIN; CENTRAL NERVOUS SYSTEM; ENCEPHALITIS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; SEPSIS; SEPSIS ASSOCIATED ENCEPHALOPATHY;

AMINES; BRAIN; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALITIS; GAMMA-AMINOBUTYRIC ACID; HUMANS; SEPSIS; SEPSIS-ASSOCIATED ENCEPHALOPATHY;

EID: 84906043208     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2013-1233     Document Type: Review

References (111)

1. Perl TM, Dvorak L, Hwang T, Wenzel RP. Long-term survival and function after suspected gram-negative sepsis. JAMA. 1995; 274:338-45
2. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA. 1997;277:1058-63
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10
4. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787-94
5. Vincent JL, Opal SM, Marshall JC, Tracey K. Sepsis definitions: time for change. Lancet. 2013;381:774-5
6. Tsung A, McCoy SL, Klune JR, Geller DA, Billiar TR, Hefeneider SH. A novel inhibitory peptide of Toll-like receptor signaling limitslipopolysaccharide-induced production of inflammatory mediators andenhances survival in mice. Shock. 2007;27:364-9
7. Song DH, Lee JO. Sensing of microbial molecular patterns by tolllike receptors. Immunol Rev. 2012;250:216-29
8. Sprung CL, Peduzzi PN, Shatney CH, Schein RM, Wilson MF, Sheagren JN, et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med. 1990;18:801-6
9. Ebersoldt M, Sharshar T, Annane D. Sepsis-associated delirium. Intensive Care Med. 2007;33:941-50
10. Kafa IM, Bakirci S, Uysal M, Kurt MA. Alterations in the brain electrical activity in a rat model of sepsis-associated encephalopathy. Brain Res. 2010;1354:217-26
11. Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennett ED. Pathophysiology of septic encephalopathy: a review. Crit Care Med. 2000;28:3019-24
12. Wilson JX, Young GB. Progress in clinical neurosciences: sepsisassociated encephalopathy: evolving concepts. Can J Neurol Sci. 2003;30:98-105
13. Barichello T, Martins MR, Reinke A, Feier G, Ritter C, Quevedo J, et al. Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med. 2005;33:221-3
14. Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson-Lohr V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;160:50-6
15. Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA. Long-term healthrelated quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life. Crit Care Med. 2000;28:3599-605
16. Angus DC, Musthafa AA, Clermont G, Griffin MF, Linde-Zwirble WT, Dremsizov TT, et al. Quality adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163:1389-94
17. Granja C, Dias C, Costa-Pereira A, Sarmento A. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness. Crit Care. 2004;8: R91-8
18. Jackson JC, Gordon SM, Ely EW, Burger C, Hopkins RO. Research issues in the evaluation of cognitive impairment in intensive care unit survivors. Intensive Care Med. 2004;30:2009-16
19. Granja C, Lopes A, Moreira S, Dias C, Costa-Pereira A, Carneiro A, et al. Patients' recollectionsof experiences in the intensive care unit may affect their quality of life. Crit Care. 2005;9:R96-109
20. Hopkins RO, Weaver LK, Collingridge D, Parkinson RB, Chan KJ, Orme JF Jr. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2005;171:340-7
21. Hough CL, Curtis JR. Long-term sequelae of critical illness: memories and health-related quality of life. Crit Care. 2005;9:145-6
22. Hopkins RO. Sepsis, oxidative stress, and brain injury. Crit Care Med. 2007;35:2233-4
23. Gordon SM, Jackson JC, Ely EW, Burger C, Hopkins RO. Clinical identification of cognitive impairment in ICU survivors: insights for intensivists. Intensive Care Med. 2004;30:1997-2008
24. van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet. 2010;375:773-5
25. Licinio J, Mastronardi C, Wong M. Pharmacogenomics of neuroimmune interactions in human psychiatric disorders. Exp Physiol. 2008;92:807-11
26. Comim CM, Vilela MC, Constantino LS, Petronilho F, Vuolo F, Lacerda-Queiroz N, et al. Traffic of leukocytes and cytokine upregulation in the central nervous system in sepsis. Intensive Care Med. 2011;37:711-8
27. Sharshar T, Gray F, Lorin de la Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet. 2003;362:1799-805
28. Weberpals M, Hermes M, Hermann S, Kummer MP, Terwel D, Semmler A, et al. NOS2 gene deficiency protects from sepsisinduced long-term cognitive deficits. J Neurosci. 2009;29:14177-84
29. Teeling JL, Perry VH. Systemic infection and inflammation in acute cns injury and chronic neurodegeneration: underlying mechanisms. Neuroscience. 2009;158:1062-73
30. Dantzer R, Bluthe RM, Gheusi G, Cremona S, Laye S, Parnet P, et al. Molecular basis of sickness behavior. Ann N Y Acad Sci. 1998;856:132-8
31. Dantzer R, Aubert A, Bluthe RM, Gheusi G, Cremona S, Laye S, et al. Mechanisms of the behavioural effects of cytokines. Adv Exp Med Biol. 1999;461:83-105
32. Dantzer R, Konsman JP, Bluthe RM, Kelley KW. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci. 2000;85:60-5
33. Khurana V, Gambhir IS, Kishore D. Evaluation of delirium in elderly: a hospital-based study. Geriatr Gerontol Int. 2011;11:467-73
34. Ek M, Kurosawa M, Lundeberg T, Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci. 1998;18:9471-79
35. Bluthe RM, Laye S, Michaud B, Combe C, Dantzer R, Parnet P. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci. 2000; 12:4447-56
36. Bluthe RM, Michaud B, Poli V, Dantzer R. Role of IL-6 in cytokineinduced sickness behavior: a study with IL-6 deficient mice. Physiol Behav. 2000;70:367-73
37. Cartmell T, Poole S, Turnbull AV, Rothwell NJ, Luheshi GN. Circulating interleukin-6 mediates the febrile response to localized inflammation in rats. J Physiol. 2000;526:653-61
38. Konsman JP, Blond D, Vigues S. Neurobiology of interleukin-1 receptors: getting the message. Eur Cytokine Netw. 2000;11: 699-702
39. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58:445-52
40. Cohen O, Reichenberg A, Perry C, Ginzberg D, Pollmacher T, Soreq H, et al. Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase. J Mol Neurosci. 2003;21:199-212
41. Krabbe KS, Reichenberg A, Yirmiya R, Smed A, Pedersen BK, Bruunsgaard H. Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun. 2005;19:453-60
42. Munster BC, Aronica E, Zwinderman AH, Eikelenboom P, Cunningham C, Rooij SE. Neuroinflammation in delirium: a postmortem case-control study. Rejuvenation Res. 2011;14: 615-22
43. McGrane S, Girard TD, Thompson JL, Shintani AK, Woodworth A, Ely W, et al. Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. Crit Care. 2011;15:R78
44. Girard TD, Ware LB, Bernard GR, Pandharipande PP, Thompson JL, Shintani AK, et al. Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive Care Med. 2012;38:1965-73
45. Pfister D, Siegemund M, Dell-Kuster S, Smielewiski P, Rüegg S, Strebel SP, et al. Cerebral perfusion in sepsis-associated delirium. Crit Care. 2008;12:R63
46. Szatmári S, Végh T, Csomós A, Hallay J, Takács I, Molnár C, et al. Impaired cerebrovascular reactivity in sepsis-associated encephalopathy studied by acetazolamide test. Crit Care. 2010;14:R50
47. Hughes CG, Morandi A, Girard TD, Riedel B, Thompson JL, Shintani AK, et al. Association between endothelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology. 2013;118:631-9
48. Møller K, Strauss GI, Qvist J, Fonsmark L, Knudsen GM, Larsen FS, et al. Cerebral Blood Flow and Oxidative Metabolism During Human Endotoxemia. J Cereb Blood Flow Metab. 2002;22: 1262-70
49. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006;7:41-53
50. Gavins F, Yilmaz G, Granger DN. The evolving paradigm for blood cell-endothelial cell interactions in the cerebral microcirculation. Microcirculation. 2007;14:667-81
51. Taccone FS, Su F, Pierrakos C, He X, James S, Dewitte O, et al. Cerebral microcirculation is impaired during sepsis: an experimental study. Crit Care. 2010;14:R140
52. He F, Peng J, Deng XL, Yang LF, Wu LW, Zhang CL, et al. RhoA and NF-kB are involved in lipopolysaccharideinduced brain microvascular cell line hyperpermeability. Neuroscience. 2011;188: 35-47
53. Wilson JX, Young GB. Sepsis-associated encephalopathy: evolving concepts. Can J Neurol Sci. 2003;30:98-105
54. Vincent JL. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology. Crit Care. 2001;5:S1-5
55. Dal-Pizzol F, Rojas HA, dos Santos EM, Vuolo F, Constantino L, Feier G, et al. Matrix Metalloproteinase-2 and Metalloproteinase-9 Activities are Associated with Blood-Brain Barrier Dysfunction in an Animal Model of Severe Sepsis. Mol Neurobiol. 2013;48:62-70
56. van den Boogaard M, Ramakers B, van Alfen N, van der Werf SP, Fick WF, Hoedemaekers CW, et al. Endotoxemia-induced inflammation and the effect on the human brain. Crit Care. 2010;14:R81
57. Grandi C, Tomasi CD, Fernandes K, Stertz L, Kapczinski F, Quevedo J, et al. Brain-derived neurotrophic factor and neuronspecific enolase, but not S100b, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care. 2011;26:133-7
58. Comim CM, Pereira JG, Steckert A, Petronilho F, Barichello T, Quevedo J, et al. Rivastigmine reverses habituation memory impairment observed in sepsis survivors rats. Shock. 2009; 32:270-1
59. Willard LB, Hauss-Wegrzyniak B, Wenk GL. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience. 1999;88:193-200
60. Ofek K, Krabbe KS, Evron T, Debecco M, Nielsen AR, Brunnsgaad H, et al. Cholinergic status modulations in human volunteers under acute inflammation. J Mol Med (Berl). 2007;85:1239-51
61. Belluardo N, Mudò G, Blum M, Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav Brain Res. 2000;113:21-34
62. Cormier A, Morin C, Zini R, Tillement JP, Lagrue G. Nicotine protects rat brain mitochondria against experimental injuries. Neuropharmacology. 2003:44:642-52
63. Guan ZZ, Yu WF, Nordberg A. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem Int. 2003;43:243-9
64. Newman MB, Arendash GW, Shytle RD, Bickford PC, Tighe T, Sanberg PR. Nicotine's oxidative and antioxidant properties in CNS. Life Sci. 2002;1:71:2807-20
65. Thomsen MS, Mikkelsen JD. The a7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-a release from microglia. J Neuroimmunol. 2012;251:65-72
66. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, Zelante T, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature. 2008;451:211-5
67. Zeden JP, Fusch G, Holtfreter B, Schefold JC, Reinke P, Domanska G, et al. Excessive tryptophan catabolism along the kynurenine pathway precedesongoing sepsis in critically ill patients. Anaesth Intensive Care. 2010;38:307-16
68. Klotz L, Sastre M, Kreutz A, Gavrilyuk V, Klockgether T, Feinstein DL, et al. Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons. J Neurochem. 2003;86:907-16
69. Shekhar A, Truitt W, Rainnie D, Sajdyk T. Role of stress, corticotrophin releasing factor and amygdala plasticity in chronic anxiety. Stress. 2005;8:209-19
70. Palomero-Gallagher N, Zilles K. Neurotransmitter receptor alterations in hepatic encephalopathy: a review. Arch Biochem Biophys 2013;536:109-21
71. van Eijk MM, Roes KC, Honing ML, Kuiper MA, Karakus A, van der Jagt M, et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomized trial. Lancet. 2010;27:376:1829-37
72. Kox M, Pompe JC, Gordinou de Gouberville MC, van der Hoeven JG, Hoedemaekers CW, Pickkers P. Effects of the a7 nicotinic acetylcholine receptor agonist gts-21 on the innate immune response in humans. Shock. 2011;36:5-11
73. Freund H, Atamian S, Holroyde J, Fischer JE. Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg. 1979;190:571-6
74. Flacker JM, Lipsitz LA. Large neutral amino acid changes and delirium in febrile elderly medical patients. J Gerontol A Biol Sci Med Sci. 2000;55:B249-52
75. van den Boogaard M, Schoonhoven L, van Achterberg T, van der Hoeven JG, Pickkers P. Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Crit Care. 2013;17:R9
76. van den Boogaard M, Pickkers P, Slooter AJ, Kuiper MA, Spronk PE, van der Voort PH, et al. Development and validation of PREDELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ. 2012;344:e420
77. Gourdin M, Dubois P, Mullier F, Chatelain B, Dogné JM, Marchandise B, et al. The effect of clonidine, as alpha-2 adrenergic receptor agonist, on inflammatory response and postischemic endothelium function during early reperfusion in healthy volunteers. J Cardiovasc Pharmacol. 2012;60:553-60
78. Jugé M, Grimaud N, Petit JY. Involvement of alpha-2 adrenergic mechanisms in experimental analgesic and anti-inflammatory activities of a benzamide derivative. Pharmacol Res. 1997;36:179-85
79. Moss RF, Parmar NK, Tihe D, Davies DC. Adrenergic agents modify cerebral edema and microvessel ultrastructure in porcine sepsis. Crit Care Med. 2004;32:1916-21
80. Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, et al. Effect of dexmdetomidine versus lorazepam on outcome outcome in patients with sepsis: an a prioridesigned analysis of the MENDS randomized controlled trial. Crit Care. 2010;14:R38
81. Wilms H, Claasen J, Röhl C, Sievers J, Deuschl G, Lucius R. Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol Dis. 2003;14:417-24
82. Tanabe K, Kozawa O, Iida H. Midazolam suppresses interleukin-1binduced interleukin-6 release from rat glial cells. J Neuroinflammation. 2011;8:68
83. Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypotesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci. 2008;63:764-72
84. Semmler A, Okulla T, Sastre M, Dumitrescu-Ozimek L, Heneka MT. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat. 2005;30:144-57
85. Belluardo N, Mudo G, Blum M, Amato G, Fuxe K. Neurotrophic effects of central nicotinic receptor activation. J Neural Transm Suppl. 2000;(60):227-45
86. Terry AV Jr, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther. 2003;306:821-7
87. Streit WJ, Sparks DL. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J Mol Med (Berl). 1997;75:130-8
88. Mrzljak L, Goldman-Rakic PS. Acetylcholinesterase reactivity in the frontal cortex of human and monkey: contribution of AChE-rich pyramidal neurons. J Comp Neurol. 1992;324:261-81
89. Hirano H, Day J, Fibiger HC. Serotonergic regulation of acetylcholine release in rat frontal cortex. J Neurochem. 1995;65:1139-45
90. Platt MM, Breitbart W, Smith M, Marotta R, Weisman H, Jacobsen PB. Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci. 1994;6:66-7
91. Wilkinson LS. The nature of interactions involving prefrontal and striatal dopamine systems. J Psychopharmacol. 1997;11:143-50
92. van der Mast RC, van den Broek WW, Fekkes D, Pepplinkhuizen L, Habbema JD. Is delirium after cardiac surgery related to plasma amino acids and physical condition? J Neuropsychiatry Clin Neurosci. 2000;12:57-63
93. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-20
94. Pandharipande PP, Morandi A, Adams JR, Girard TD, Thompson JL, Shintani AK, et al. Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. Intensive Care Med. 2009;35:1886-92
95. Berg RM, Taudorf S, Bailey DM, Lundby C, Larsen FS, Pedersen BK, et al. Cerebral net exchange of large neutral amino acids afterlipopolysaccharide infusion in healthy humans. Crit Care. 2010;14:R16
96. Freund HR, Ryan JA Jr, Fischer JE. Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions. Ann Surg. 1978;188:423-30
97. Adams Wilson JR, Morandi A, Girard TD, Thompson JL, Boomershine CS, Shintani AK, et al. The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness. Crit Care Med. 2012;40:835-41
98. Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebocontrolled trial. Crit Care Med. 2010;38:428-37
99. O'Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol. 2009;12:687-99
100. Brede M, Braeuninger S, Langhauser F, Hein L, Roewer N, Stoll G, et al. alpha2-adrenoceptors do not mediate neuroprotection in acute ischemic stroke in mice. J Cereb Blood Flow Metab. 2011;31:e1-7
101. Wohleb ES, Hanke ML, Corona AW, Powell ND, Stiner LM, Bailey MT, et al. β-adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci. 2011;31:6277-88
102. Markus T, Hansson SR, Cronberg T, Cilio C, Wieloch T, Ley D. β-adrenoceptor activation depresses brain inflammation and is neuroprotective in lipopolysaccharide-induced sensitization to oxygen-glucose deprivation in organotypic hippocampal slices. J Neuroinflammation. 2010;7:94
103. Gleeson LC, Ryan KJ, Griffin EW, Connor TJ, Harkin A. The b2-adrenoceptor agonist clenbuterol elicits neuroprotective, antiinflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. Brain Behav Immun. 2010;24:1354-61
104. Price LH, Goddard AW, Barr LC, Godman WK. Anxiety disorders: pharmacological challenges in anxiety disorders. In: Bloom FE, Kupfer DJ. Psychopharmacology: the fourth generation of progress. An official publication of the American College of Neuropsychopharmacology. New York: Raven Press; 1995. p. 1287-359
105. Mora F, Segovia G, Del Arco A, de Blas M, Garrido P. Stress, neurotransmitters, corticosterone and body-brain integration. Brain Res. 2012;1476:71-85
106. Wang DS, Zurek AA, Lecker I, Yu J, Abramian AM, Avramescu S, et al. Memory deficits induced by inflammation are regulated by a5-subunit-containing GABAA receptors. Cell Rep. 2012;2: 488-96
107. Kadoi Y, Saito S. An alteration in the gamma-aminobutyric acid receptor system in experimentally induced septic shock in rats. Crit Care Med. 1996;24:298-305
108. Komatsubara T, Kadoi Y, Saito S. Augmented sensitivity to benzodiazepine in septic shock rats. Can J Anaesth. 1995;42:937-43
109. Boegel K, Gyulai FE, Moore KK, Gold MS. Deleterious impact of a c-aminobutyric acid type A receptor preferring general anesthetic when used in the presence of persistent inflammation. Anesthesiology. 2011;115:782-90
110. Matsumoto T, Ogata M, Koga K, Shigematsu A. Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice. Antimicrob Agents Chemother. 1994;38:812-6
111. Lei B, Popp S, Cottrell JE, Kass IS. Effects of midazolam on brain injury after transient focal cerebral ischemia in rats. J Neurosurg Anesthesiol. 2009;21:131-9.